Point-of-Care System for Determination of Bilirubin Capacity in Neonates

Inclusion Criteria are in vitro testing of blood samples obtained from eligible babies: * Subjects must meet all of the following inclusion criteria to be considered eligible for study enrollment soon after birth or re-admission (for phototherapy): * Parental informed consent * Male and female newborns with a GA ≥ 24 wks with a birthweight ≥ 500 g as well as sick or unstable late preterm newborns infants with GA ≥ 35 wks with a birthweight ≥ 2500 g. * Enrollment at age less than 14 days and more than 6h Exclusion Criteria: * None.